Human NK Cells in Health and Disease: Clinical, Functional, Phenotypic and DNA Genotypic Characteristics

References

• Kabelitz D. Human cytotoxic lymphocytes. IV. Frequency and clonal specificity of CD8+ CD16− (Leu2+-Leull−) and CD16+ CD3− (Leu11 + Leu4−) cytotoxic lymphocyte precursors activated by alloantigen or K562 stimulator cells. Cell Immunol. 1989; 121: 298–305
   PubMed Web of Science ®Google Scholar
• Takasugi M., Mickey M. R., Terasaki P. I. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer. Res. 1973; 33: 2898–2902
   PubMed Web of Science ®Google Scholar
• Rosenberg E. B., McCoy J. L., Green S. S., Donnelly F. C., Siwarski D. F., Levine P. H., Herberman R. B. Destruction of human lymphoid tissue culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J. Natl. Cancer. Inst. 1974; 52: 345–352
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Phillips J. H. Evidence for three types of human cytotoxic lymphocytes. Immunol. Today. 1986; 7: 132–134
   PubMedGoogle Scholar
• Doyle C., Strominger J. L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256–259
   PubMed Web of Science ®Google Scholar
• Norment A. M., Salter R. D., Parham P., Engelhard V. H., Littman D. R. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988; 336: 79–81
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Kipps T. J., Phillips J. H. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fe receptors for IgG (CD16/leu-11 antigen). J. Exp. Med 1985; 162: 2089–2106
   PubMed Web of Science ®Google Scholar
• Brenner M. B., McLean J., Dialynas D. P., Strominger J. L., Smith J. A., Owen F. L., Seidman J. G., Ip S., Rosen F., Krangel M. S. Indentification of a putative second T-cell receptor. Nature 1986; 322: 145–149
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Ruitenberg J. J., Phillips J. H. Human CD3+ T lymphocytes that express neither CD4 nor CD8 antigens. J. Exp. Med. 1986; 164: 339–344
   PubMed Web of Science ®Google Scholar
• Grimm E. A., Mazumder A., Zhang H. Z., Rosenburg S. A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp. Med. 1982; 155: 1823–1841
   PubMed Web of Science ®Google Scholar
• Timonen T., Saksela E., Ranki A., Hayry P. Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell. Immunol 1979; 48: 133–148
   PubMed Web of Science ®Google Scholar
• Timonen T., Ortaldo J. R., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp. Med. 1981; 153: 569–582
   PubMed Web of Science ®Google Scholar
• Karre K., Hansson M., Kiessling R. Multiple interactions at the natural killer workshop. Immunol. Today. 1991; 12: 343–345
   PubMedGoogle Scholar
• Kay H. D., Bonnard G. D., West W. H., Herbermann R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol 1977; 118: 2058–2066
   PubMed Web of Science ®Google Scholar
• Ozer H., Strelkauskas A. J., Callery R. T., Schlossman S. F. The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing. Eur. J. Immunol 1979; 9: 112–118
   PubMed Web of Science ®Google Scholar
• Perussia B., Trinchieri G., Jackson A., Warner N. L., Faust J., Ruampold H., Kraft D., Lanier L. L. The Fe receptor on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J. Immunol 1984; 133: 180–189
   PubMed Web of Science ®Google Scholar
• Levy P. C., Shaw G. M., LoBuglio A. F. Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis. J. Immunol 1979; 123: 594–599
   PubMed Web of Science ®Google Scholar
• Van Kessel K. P. M., Verhoef J. A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells. Pathobiology 1990; 58: 249–264
   PubMed Web of Science ®Google Scholar
• Schlossman S. F., Chess L. Immunological functions of a subset of human null cells. Clinical Evaluation of Immune Function in Man. Grune and Stratton, New York 1976; 65–95
   Google Scholar
• Mc Michael A. J. Leucocyte Typing III: White Cell Differentiation Antigens. Oxford University Press, Oxford 1987
   Google Scholar
• Knapp W., Dorken B., Gilks W. R., Rieber E. P., Schmidt R. E., Stein H., von dem Borne A. E. G. Leucocyte Typing IV. Oxford University Press, Oxford 1989
   Google Scholar
• Jondal M., Pross H. Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int. J. Cancer 1975; 15: 596–605
   PubMed Web of Science ®Google Scholar
• Santoli D., Trinchieri G., Moretta L., Zmijewski D. M., Koprowski H. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell. Clin. Exp. Immunol 1978; 33: 309–318
   PubMed Web of Science ®Google Scholar
• Fitzgerald-Bocarsly P., Herberman R., Hercend T., Hiserodt J., Kumar V., Lanier L., Ortaldo J., Pross H., Reynolds C., Welsh R., Wigzell H. A definition of natural killer cells. Immunol. Today. 1988; 9: 292
   Google Scholar
• Lanier L. L., Le A. M., Civin C. I., Loken M. R., Phillips J. H. The relationship of CD16 (leu-11) and leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic lymphocytes. J. Immunol 1986; 136: 4480–4486
   PubMed Web of Science ®Google Scholar
• Perussia B., Trinchieri G. Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. J. Immunol. 1984; 132: 1410–1415
   PubMed Web of Science ®Google Scholar
• Anegon I., Cuturi M. C., Trinchieri G., Perussia B. Interaction of Fc receptor (CD 16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med 1988; 167: 452–472
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Ruitenberg J. J., Phillips J. H. Functional and biochemical analysis of CD 16 antigen on natural killer cells and granulocytes. J. Immunol 1988; 141: 3478–3485
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Yu G., Phillips J. H. Co-association of CD3C with a receptor (CD 16) for IgG Fc on human natural killer cells. Nature 1988; 342: 803–805
   Web of Science ®Google Scholar
• Griffin J. D., Hercend T., Beveridge R., Schlossman S. F. Characterization of an antigen expressed by human natural killer cells. J. Immunol 1983; 130: 2947–2951
   PubMed Web of Science ®Google Scholar
• Hercend T., Griffin J. D., Bensussan A., Schmidt R. E., Edson M. A., Brennan A., Murray C., Daley J. F., Schlossman S. F., Ritz J. Generation of monoclonal antibodies to a human natural killer clone. J. Clin. Invest. 1985; 75: 932–943
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Chang C., Azuma M., Ruitenberg J. J., Hemperly J. J., Phillips J. H. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J. Immunol. 1991; 146: 4421–4426
   PubMed Web of Science ®Google Scholar
• Robertson M. J., Caligiuri M. A., Manley T. J., Levine H., Ritz J. R. Human natural killer cell adhesion molecules. J. Immunol. 1990; 145: 3194–3201
   PubMed Web of Science ®Google Scholar
• Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J. Immunol. 1981; 127: 1024–1029
   PubMed Web of Science ®Google Scholar
• Abo T., Cooper M. D., Balch C. M. Characterization of HNK-I+ (leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability. J. Immunol 1982; 129: 1752–1757
   PubMed Web of Science ®Google Scholar
• Perussia B., Fanning V., Trinchieri G. A human NK and K cell subset shares with cytotoxic T cell expression of the antigen recognized by antibody OKT8. J. Immunol 1983; 131: 223
   PubMed Web of Science ®Google Scholar
• Gadd S. Cluster report: CD13. Leucocyte Typing IV. White Cell Differentiation Antigens. Oxford University Press, Oxford 1989a; 782–784
   Google Scholar
• Gadd S. Cluster report: CD14. Leucocyte Typing IV. White Cell Differentiation Antigens, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. von dem Borne. Oxford University Press, Oxford 1989b; 787–789
   Google Scholar
• Koller S., Peschel Ch. Cluster report: CD33. Oxford University Press, Oxford 1989; 812–813
   Google Scholar
• Arnout M. A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75: 1037–1050
   PubMed Web of Science ®Google Scholar
• Springer T. A. Adhesion receptors in the immune system. Nature 1990; 346: 425–433
   PubMed Web of Science ®Google Scholar
• Timonen T., Patarroyo M., Gahmberg C. G. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J. Immunol. 1988; 141: 1041–1046
   PubMed Web of Science ®Google Scholar
• Ball E. D., Schwarz L. M., Bloomfield C. D. Expression of the CD15 antigen on normal and leukemic myeloid cells: Effects of neuraminidase and variable detection with a panel of monoclonal antibodies. Mol Immunol 1991; 28: 951–958
   PubMed Web of Science ®Google Scholar
• Richards S. J., Scott C. S. Immunophenotypic dissection of normal peripheral blood NK associated (NKa) subpopulations by flow cytometry: Morphological features and relationships between membrane NKa (CD11b, CD16, CD56 and CD57) and T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) associated determinant expression. Leuk. Lymphoma. 1990; 2: 111–126
   PubMedGoogle Scholar
• Moebius U., Kober G., Griscelli A. L., Hercend T., Meuer S. C. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 1991; 21: 1793–1800
   PubMed Web of Science ®Google Scholar
• Lanier L. L., Loken M. R. Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: Correlation of leu-2, leu-3, leu-7, leu-8 and leu-11 cell surface antigen expression. J. Immunol. 1984; 132: 151–156
   PubMed Web of Science ®Google Scholar
• Scott C. S., Richards S. J., Galvin M. C., Child J. A., Hunt K. M., McEvoy M. W., Steed A. J., Sivakumaran M., Short M., Roberts B. E. Transient and persistent expansions of large granular lymphocytes (LGL) and NK-associated (NKa) cells: The Yorkshire Leukaemia Group study: in preparation. 1992
   Google Scholar
• Richards S. J., Jones R. A., Roberts B. E., Patel D., Scott C. S. Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8−, CD4CD8+, CD4−CD8 dim+, CD3 + CD4−CD8− and CD3− CD4−CD8− lymphocytes. Clin. Exp. Immunol. 1990; 81: 149–155
   PubMed Web of Science ®Google Scholar
• Clement L. T., Yamashita N., Martin A. M. The functional subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J. Immunol. 1988; 141: 1464–1471
   PubMed Web of Science ®Google Scholar
• Akbar A. N., Terry L., Timms S., Beverley P. C. L., Janossy G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J. Immunol 1988; 140: 2171–2177
   PubMed Web of Science ®Google Scholar
• Yamashita N., Clement L. T. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes. J. Immunol 1989; 143: 1518–1525
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Perussia B. Biology of disease. Human natural killer cells: Biologic and pathologic aspects. Lab. Invest. 1984; 50: 489–513
   PubMed Web of Science ®Google Scholar
• Plum J., Koning F., Leclercq G., Tison B., De Smedt M. Expansion of large granular lymphocytes in IL-2-driven 14-day-old fetal thymocytes in organ culture. J. Immunol. 1990; 144: 3710–3717
   PubMed Web of Science ®Google Scholar
• Maghazachi A. A., Vujanovic N. L., Herberman R. B., Hiserodt J. C. Lymphokine-activated killer cells in rats: IV, Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. J. Immunol. 1988; 140: 2846–2852
   PubMed Web of Science ®Google Scholar
• Michon J. M., Caligiuri M. A., Hazanow S. M., Levine H., Schlossman S. F., Ritz J. Induction of natural killer effectors from human thymus with recombinant IL-2. J. Immunol. 1988; 140: 3660–3667
   PubMed Web of Science ®Google Scholar
• Blue M.-L., Levine H., Daley J. F., Craig K. A., Schlossman S. A. Development of natural killer cells in human thymocyte culture: regulation by accessory cells. Eur. J. Immunol 1987; 17: 669–673
   PubMed Web of Science ®Google Scholar
• Lotzovo E., Savary C. A. Generation of NK cell activity from human bone marrow. J. Immunol 1987; 139: 279–284
   PubMed Web of Science ®Google Scholar
• Janeway C. A. A primitive immune system. Nature 1989; 341: 108
   PubMed Web of Science ®Google Scholar
• Anderson P., Caligiuri M., Ritz J., Schlossman S. F. CD3-negative natural killer cells express TCR as part of a novel molecular complex. Nature 1989; 341: 159–162
   PubMed Web of Science ®Google Scholar
• Ruthlein J., James S. P., Strober W. Role of CD2 activation and cytotoxic function of CD8/leu-7-positive T cells. J. Immunol 1988; 141: 3791–3797
   PubMed Web of Science ®Google Scholar
• Abo T., Miller C. A., Gartland G. L., Balch C. M. Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life. J. Exp. Med 1983; 157: 273–279
   PubMed Web of Science ®Google Scholar
• Oshimi K. Granular lymphocyte proliferative disorders: Report of 12 cases and review of the literature. Leukemia 1988; 2: 617–627
   PubMed Web of Science ®Google Scholar
• Phillips J. H., Lanier L. L. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 1986; 164: 814–825
   PubMed Web of Science ®Google Scholar
• Nagler A., Lanier L. L., Cwirla S., Phillips J. H. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol 1989; 143: 3183–3191
   PubMed Web of Science ®Google Scholar
• Braakman E., Sturm E., Vijverberg K., van Krimpen B. A., Gratama J. W., Bolhuis R. L. Expression of CD45 isoforms by fresh and activated γ T lymphocytes and natural killer cells. J. Immunol 1991; 3: 691–697
   Google Scholar
• London L., Perussia B., Trinchieri G. Induction of proliferation in vitro of resting human natural killer cells: Expression of surface activation antigens. J Immunol 1985; 134: 718–727
   PubMed Web of Science ®Google Scholar
• Fuchshuber P. R., Lotzova E., Pollock R. E. Antitumor activity, growth and phenotype of long-term IL-2 cultures of human NK and T lymphocytes. Lymph. Cyto. Res. 1991; 10: 51–59
   PubMedGoogle Scholar
• Ortaldo J. R., Winkler-Pickett R. T., Yagita H., Young H. A. Comparative studies of CD3− and CD3+ CD56+ cells: Examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell. Immunol 1991; 136: 486–495
   PubMed Web of Science ®Google Scholar
• Koberda J., Bergmann L., Mitrou P. S., Hoelzer D. High release of tumor necrosis fractor α, inteferon γ and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells. J. Cancer Res. Clin. Oncol. 1991; 117: 425–430
   PubMed Web of Science ®Google Scholar
• Ritz J. The role of natural killer cells in immune surveillance. New. Engl. J. Med 1989; 320: 1748–1749
   PubMed Web of Science ®Google Scholar
• Garcia-Penarrubia P., Koster F. T., Kelley R. O., McDowell T. D., Bankhurst A. D. Antibacterial activity of human natural killer cells. J. Exp. Med. 1989; 169: 99–113
   PubMed Web of Science ®Google Scholar
• Biron C. A., Natuk R. J., Welsh R. M. Generation of large granular T lymphocytes in vivo during viral infection. J. Immunol. 1986; 136: 2280–2286
   PubMed Web of Science ®Google Scholar
• Agostini C., Zambello R., Pontisso P., Alberti A., Trentin L., Siviero F., Foa R., Pandolfi F., Semenzato G. Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes. J. Clin. Immunol. 1989; 9: 401–408
   PubMed Web of Science ®Google Scholar
• Biron C. A., Byron K. S., Sullivan J. L. Severe herpes virus infections in an adolescent without natural killer cells. New. Engl. J. Med 1989; 320: 1731–1735
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Oldham R. K., Cannon G. C., Herberman R. B. Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J. Natl. Cancer. Inst. 1977; 59: 77–82
   PubMed Web of Science ®Google Scholar
• Lozzio B. B., Lozzio C. B., Machado E. Human myelogenous (Ph+) leukemia cell line: transplantation into athymic mice. J. Natl. Cancer. Inst. 1976; 56: 627–629
   PubMed Web of Science ®Google Scholar
• Brunner K. T., Mauel J., Cerottini J.-C., Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; Inhibition by isoantibody and by drugs. Immunology 1968; 14: 181–196
   PubMed Web of Science ®Google Scholar
• Persussia B., Trinchieri G., Cerottini J.-C. Functional studies of Fc receptor-bearing human lymphocytes: Effect of treatment with proteolytic enzymes. J. Immunol 1979; 123: 681–687
   PubMed Web of Science ®Google Scholar
• Radcliff G., Waite R., LeFevre J., Poulik M. D., Callewaert D. M. Quantification of effector/target conjugation involving natural killer (NK) or lymphokine activated killer (LAK) cells by two-color flow cytometry. J. Immunol. Methods 1991; 139: 281–292
   PubMed Web of Science ®Google Scholar
• Papa S., Vitale M., Mariani A. R., Roda P., Facchini A., Manzoli F. A. Natural killer function in flow cytometry. I. Evaluatation of NK lytic activity on the K562 cell line. J. Immunol. Methods 1988; 107: 73–78
   PubMed Web of Science ®Google Scholar
• Radosevic K., Garritsen H. S. P., Graft M., Grooth B. G., Greve J. A simple and sensitive flow cytometric assay for the determination of the cytolytic activity of human natural killer cells. J. Immunol. Methods 1990; 135: 81–89
   PubMed Web of Science ®Google Scholar
• Vitale M., Neri L. M., Comani S., Falcieri E., Rizzoli R., Rana R., Papa S. Natural killer function in flow cytometry. II. Evaluation of NK lytic activity by means of target cell morphological changes detected by right angle light scatter. J Immunol. Methods 1989; 121: 115–120
   PubMed Web of Science ®Google Scholar
• Yannelli J., Maleckar J., West W., Oldham R. Cellular biotherapy of cancer: generation, characterization, and use of anti-tumour effector cells. Cellular biotherapy of cancer: generation, characterization, and use of anti-tumour effector cells, R. C. Rees. Oxford University Press, New York 1990; 120–138
   Google Scholar
• Fierro M. T., Liao X.-S., Lusso P., Bonferroni M., Matera L., Cesano A., Lista P., Arione R., Forni G., Foa R. In vilro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. Leukemia 1988; 2: 50–54
   PubMed Web of Science ®Google Scholar
• Horton S. A., Oldham R. K., Yannelli J. R. Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2. Cancer. Res. 1990; 50: 1686–1692
   PubMed Web of Science ®Google Scholar
• Timonen T., Ortaldo J. R., Herberman R. B. Analysis, by a single cell cytotoxicity assay of natural killer (NK) cell frequencies among large granular lymphocytes and of the effects of interferon on their activity. J Immunol. 1982; 128: 2514–2521
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Granato D., Perussia B. Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J. Immunol. 1981; 126: 335–340
   PubMed Web of Science ®Google Scholar
• Vitale M., Zamai L., Neri L. M., Manzoli L., Facchni A., Papa S. Natural killer cell function in flow cytometry: Identification of human lymphoid subsets able to bind to the NK sensitive target K562. Cytometry. 1991; 12: 717–722
   PubMedGoogle Scholar
• Scott C. S., Richards S. J., Roberts B. E. Patterns of membrane TCRa α, β J and TCRγ, chain expression by normal blood CD4+ CD8−, CD4−CD8+, CD4−CD8dim+ and CD4− CD8− lymphocytes. Immunology 1990; 70: 351–356
   PubMed Web of Science ®Google Scholar
• van deGriend R. J., Bolhuis R. L. H., Stoter G., Roozemond R. C. Regulation of cytolytic activity on CD3− and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR. J. Immunol. 1987; 138: 3137–3144
   PubMed Web of Science ®Google Scholar
• Alarcon B., Fresno M. Specific effect of anti transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells. J. Immunol. 1985; 134: 1286–1291
   PubMed Web of Science ®Google Scholar
• Perl A., Looney R. J., Ryan D. H., Abraham G. N. The low affinity 40,000 Fey receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing. J. Immunol. 1986; 136: 4714–4720
   PubMed Web of Science ®Google Scholar
• Bridges K. R., Smith B. R. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells. J. Clin. Invest. 1985; 76: 913–918
   PubMed Web of Science ®Google Scholar
• Schmidt R. E., Caulfield J. P., Michon J., Hein A., Kamada M. M., MacDermott R. P., Stevens R. L., Ritz J. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. J. Immunol. 1988; 140: 991–1002
   PubMed Web of Science ®Google Scholar
• Mullbacher A., King N. J. C. Target cell lysis by natural killer cells is influenced by β2-microglobulin expression. Scand. J. Immunol. 1989; 30: 21–29
   PubMed Web of Science ®Google Scholar
• Petranyi G. G., Pocsik E., Kotlan B., Gorog G., Benczur M. Regulatory function of cell surface molecules CD2-, LFA- and β2-microglobulin in natural killer activity. Mol. Immunol. 1986; 23: 1275–1281
   PubMed Web of Science ®Google Scholar
• Storkus W. J., Howell D. N., Salter R. D., Dawson J. R., Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 1987; 138: 1657–1659
   PubMed Web of Science ®Google Scholar
• Dennert G., Landon C., Lord E. M., Bahler D. W., Frelinger J. G. Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens. J. Immunol. 1988; 140: 2472–2475
   PubMed Web of Science ®Google Scholar
• Reiter Z., Reiter Y., Fishelso Z., Shinitsky M., Kessler A., Loyter A., Nussbaum O., Rubinstein M. Resistance to NK cell-mediated cytotoxicity (in K562 cells) does not correlate with Class I MHC antigen levels. Immunobioloay. 1991; 183: 23–29
   PubMed Web of Science ®Google Scholar
• Jones R. A., Richards S. J., Patel D., Scott C. S. Suppression of natural killer cell activity by rabbit antibody to human beta2-microglobulin (β2m) is an Fc-mediated phenomenom and is not β2m specific. Immunobioloay. 1991; 73: 342–347
   Google Scholar
• Berke G. Lymphocyte-triggered internal target disintegration. Immunol. Today. 1991; 12: 396–399
   PubMedGoogle Scholar
• Dealtry G. B., Naylor M. S., Fiers W., Balkwill F. R. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-γ. Eur. J. Immunol. 1987; 17: 689–693
   PubMed Web of Science ®Google Scholar
• Grossi C. E., Cadoni A., Zicca A., Leprini A., Ferrarini M. Large granular lymphocytes in human peripheral blood: Ultrastructural and cytochemical characterization of the granules. Blood 1982; 59: 277–283
   PubMed Web of Science ®Google Scholar
• Heumann D., Colombatti M., Mach J.-P. Human large granular lymphocytes contain an esterase activity usually considered as specific for the myeloid series. Eur. J. Immunol. 1983; 13: 254–258
   PubMed Web of Science ®Google Scholar
• Zalman L. S., Brothers M. A., Chiu F. J., Muller-Eberhard H. J. Mechanism of cytotoxicity of human large granular lymphocytes: Relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement. Proe. Natl. Acad. Sci. USA 1986; 83: 5262–5266
   PubMed Web of Science ®Google Scholar
• Liu C. C., Perussia B., Cohn Z. A., Young J. D. Identification and characterization of a pore-forming protein of human natural killer cells. J Exp. Med. 1986; 164: 2061–2076
   PubMed Web of Science ®Google Scholar
• Lichtenheld M. G., Olsen K. J., Lu P., Lowrey D. M., Hameed A., Hengartner H., Podack E. R. Structure and function of human perforin. Nature 1988; 335: 448–451
   PubMed Web of Science ®Google Scholar
• Shinkai Y., Takio K., Okumura K. Homology of perforin to the ninth component of complement (C9). Nature 1988; 334: 525–527
   PubMed Web of Science ®Google Scholar
• Krahnenbuhl O., Tschopp J. Perforin-induced pore formation. Immunol. Today. 1991; 12: 399–402
   PubMedGoogle Scholar
• Chow S. C., Jondal M. A central role for phosphoinositide hydrolysis in activating the lytic mechanism of human killer cells. Immunology 1990; 70: 106–110
   PubMed Web of Science ®Google Scholar
• Wright S. C., Bonavida B. Studies on the mechanism of natural killer cell-mediated cytotoxicity. J. Immunol. 1987; 138: 1791–1798
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. J. Exp. Med. 1978; 5: 1314–1333
   Web of Science ®Google Scholar
• Trinchieri G., Santoli D., Koprowski H. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J. Immunol. 1978; 120: 1849–1855
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Matsumoto-Kobayashi M., Clark S. C., Seehra J., London L., Perussia B. Response of resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med. 1984; 160: 1147–1169
   PubMed Web of Science ®Google Scholar
• Henney C. S., Kuribayashi K., Kern D. E., Gillis S. Interleukin-2 augments natural killer activity. Nature 1981; 291: 335–338
   PubMed Web of Science ®Google Scholar
• Sharon M., Klausner R. D., Cullen B. R., Chizzonite R., Leonard W. J. Novel interleukin-2 receptor subunit detected by cross-linking under high affinity conditions. Science 1986; 234: 859–863
   PubMed Web of Science ®Google Scholar
• Teshigawara K., Wang H.-M., Kato K., Smith K. A. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J. Exp. Med. 1987; 165: 223–238
   PubMed Web of Science ®Google Scholar
• Umehara H., Bloom E. T. The IL-2 receptor beta subunit is absolutely required for mediating the IL-2-induced activation of NK activity and proliferative activity of human large granular lymphocytes. Immunology 1990; 70: 111–115
   PubMed Web of Science ®Google Scholar
• Robb R. J., Rusk C. M., Neeper M. P. Structure-function relationships for the interleukin 2 receptor: Location of ligand and antibody binding sites cm the Tac receptor chain by mutational analysis. Proc. Natl. Acad. Sci. USA 1988; 85: 5654–5663
   PubMed Web of Science ®Google Scholar
• Tsudo M., Goldman C. K., Bongiovanni K. F., Chan W. C., Winton E. F., Yagita M., Grimm E. A., Waldman T. A. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Acad. Sci. USA 1986; 84: 5394–5398
   Web of Science ®Google Scholar
• Brunda M. J., Tarnowski D., Davatelis V. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2 activated killer cells. Int. J. Cancer 1986; 37: 787–793
   PubMed Web of Science ®Google Scholar
• Silva A., Bonavida B., Targan S. Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis. J. Immunol 1980; 125: 479–484
   PubMed Web of Science ®Google Scholar
• Targen S., Dorey F. Interferon activation of ‘pre-spontaneous killer’ (pre-SK) cells and alteration in kinetics of lysis of both ‘pre-SK’ and active SK cells. J. Immunol. 1980; 124: 2157–2161
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989; 170: 827–845
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Mason A. T., Gerard J. P., Henderson L. E., Farrar W., Hopkins I II, R F., Herberman R. B., Rabin H. Effects of natural and recombinant IL-2 on regulation of IFNy production and natural killer activity: Lack of involvement of the Tac antigen for these immunoregulatory effects. J. Immunol 1984; 133: 779–783
   PubMed Web of Science ®Google Scholar
• Kasahara T., Djeu J. Y., Dougherty S. F., Oppenheim J. J. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor. J. Immunol. 1983; 131: 2379–2385
   PubMed Web of Science ®Google Scholar
• Mingari M. C., Ferrini S., Pende D., Bottino C., Prigione I., Moretta A., Moretta L. Phenotypic and functional analysis of human CD3+ and CD3 clones with ‘lymphokine-activated killer’ (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2. Int. J. Cancer 1987; 40: 495–498
   PubMed Web of Science ®Google Scholar
• Cuturi M. C., Anegon I., Sherman F., Loudon R., Clark S. C., Perussia B., Trinchieri G. Production of hematopoietic colony-stimulating factors by human natural killer cells. J Exp. Med 1989; 169: 569–583
   PubMed Web of Science ®Google Scholar
• Procopio A. D. G., Allavena P., Ortaldo J. R. Noncytotoxic functions of natural killer (NK) cells: Large granular lymphocytes (LGL) produce a B cell growth factor (BCGF). J. Immunol 1985; 135: 3264–3271
   PubMed Web of Science ®Google Scholar
• Mc Glone J. J., Lumpkin E. E., Norman R. L. Adrenocorticotropin stimulates natural killer cell activity. Endocrinology 1991; 129: 1653–1658
   PubMed Web of Science ®Google Scholar
• Leu S., Sigh V. K. Modulation of natural killer cell-mediated lysis by corticotropin-releasing neurohormone. J. Neuroimmunol 1991; 33: 253–260
   PubMed Web of Science ®Google Scholar
• Nagler A., Greenberg P. L. Bone marrow modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells. Int. J. Cell. Cloning. 1990; 8: 171–183
   PubMedGoogle Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Lineham W. M., Robertson C. N., Lee R. E., Rubin J. T., Seipp, Simpson C. A., White D. E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. New. Engl. J. Med 1987; 316: 889–879
   PubMed Web of Science ®Google Scholar
• West W. H., Tauer K. W., Yanelli J. R., Marshall G. D., Orr D. W., Thurman G. B., Oldham R. K. Constant infusion recombinant interleukin-2 in adoptive immunotherapy of cancer. New. Engl. J. Med. 1987; 316: 898–905
   PubMed Web of Science ®Google Scholar
• Melder R. J., Whiteside T. L., Vujanovic N. L., Hiserodt J. C., Herbermann R. B. A new approach to generating antitumor effects for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res. 1988; 48: 3461–3469
   PubMed Web of Science ®Google Scholar
• Lotzova E. Natural killer cells: Immunobiology and clinical prospects. Cancer Invest. 1991; 9: 173–184
   PubMed Web of Science ®Google Scholar
• Barlozzari T., Leonhardt J., Wiltrout R. H., Herbermann R. B., Reynolds C. W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol 1985; 134: 2783–2789
   PubMed Web of Science ®Google Scholar
• Gorelik E. L., Herberman R. B. Immunological control of tumor metastases. Immunological control of tumor metastases, R. H. Goldfarb. Kluwer Academic Publishers, DordrechtNetherlands 1989; 134–143
   Google Scholar
• Kakumu S., Hirofuji H., Fuji A., Tahara H., Yashioka K. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma. J. Clin. Lab. Immunol 1988; 26: 29–32
   PubMedGoogle Scholar
• Le Fever A. V., Funahashi A. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Res. 1991; 51: 5596–5601
   PubMed Web of Science ®Google Scholar
• Griffin D. E., Ward B. J., Jauregui E., Johnson R. T., Vaisberg A. Natural killer cell activity during measles. Clin. Exp. Immunol 1990; 81: 218–224
   PubMed Web of Science ®Google Scholar
• Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977; 37: 413–418
   PubMed Web of Science ®Google Scholar
• Steinhauer E. H., Doyle A. T., Reed J., Kadish A. S. Effective natural cytotoxicity in patients with cancer: Normal numbers of effector cells but decreased cycling capacity in patients with advanced disease. J. Immunol 1982; 129: 2255–2259
   PubMed Web of Science ®Google Scholar
• Eremin O., Coombs R. R.A., Ashby J. Lymphocytes infiltrating human breast cancer lack K-cell activity and show low levels of NK-cell activity. Br. J. Cancer 1981; 44: 166–176
   PubMed Web of Science ®Google Scholar
• Nakanishi H., Monden T., Morimoto H., Koyabashi T., Shimano T., Mori T. Perforin expression in lymphocytes infiltrated to human colorectal cancer. Br. J. Cancer 1991; 64: 239–242
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Biology of natural killer cells. Adv. Immunol 1989; 47: 187–376
   PubMed Web of Science ®Google Scholar
• Hanto D., Frizzera G., Gajil-Peczalski K., Simmons R. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461–472
   PubMed Web of Science ®Google Scholar
• Purtilo D., Sakamoto K., Saemundson A., Sullivan J. L., Synnerholm A. C., Anvret M. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological and immunopathological studies. Cancer Res. 1981; 41: 4226–4235
   PubMed Web of Science ®Google Scholar
• Haliotis T., Roder J. C., Klein M., Ortaldo J., Fauci A. S., Herberman R. B. Chediak-Higashi gene in humans. I. Impairment of natural killer function. J. Exp. Med. 1980; 151: 1029–1048
   Web of Science ®Google Scholar
• Roder J. C., Haliotis T., Klein M., Korec S., Jett J. R. A new immunodificiency disorder in humans involving NK cells. Nature 1980; 284: 553–555
   PubMed Web of Science ®Google Scholar
• Strayer D. R., Carter W. A., Mayberry S. D., Pequignot E., Brodsky I. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer. Res. 1984; 44: 370–374
   PubMed Web of Science ®Google Scholar
• Guanti G., Massari S., Cristofaro G., Carusco M. L., Porsia R., Stella A., Susca F., Tauro A., Giorgio I. Depressed levels of natural killer cells in cancer family syndrome. Cancer Immunol. Immunother. 1989; 30: 307–311
   PubMed Web of Science ®Google Scholar
• Hersey P., Edwards A., Honeyman M., Mc Carthy W. H. Low natural killer-cell activity in familial melanoma patients and their relatives. Br. J. Cancer 1979; 40: 113–122
   PubMed Web of Science ®Google Scholar
• Strayer D. R., Carter W. A., Brodsky I. Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity. Breast. Cancer. Res. Treat. 1986; 7: 187–192
   PubMed Web of Science ®Google Scholar
• Foa R., Fierro M. T., Cesano A., Guarini A., Bonferroni M., Raspadori D., Miniero R., Lauria F., Gavosto F. Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease. Blood 1991; 78: 1041–1046
   PubMed Web of Science ®Google Scholar
• Dickinson A. M., Proctor S. J., Jacobs E., Reid M. M., Walker W., Craft A. W., Kernahan J. Natural killer activity in childhood acute lymphoblastic leukaemia in remission. Br. J. Haematol. 1985; 59: 45–53
   PubMed Web of Science ®Google Scholar
• Yoda Y., Abe T., Tashiro A., Hirosawa S., Kawada K., Onozawa Y., Adachi Y., Shishido H., Nomara T. Normalized natural killer (NK) cell activity in long-term remission of acute leukaemia. Br. J. Haematol 1983; 55: 305–309
   PubMed Web of Science ®Google Scholar
• Ruco L. P., Procopio A., Maccallini V., Calogero A., Uccini S., Annino L., Madelli F., Baroni C. D. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 1983; 61: 1132–1137
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Ambrosetti A., Chisesi T., Raimondi R., Bulian P., Pizzolo G., Semenzato G. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 1990; 75: 1525–1530
   PubMed Web of Science ®Google Scholar
• Takagi S., Kitagawa S., Takeda A., Minato N., Takaku F., Miura Y. Natural killer-interferon system in patients with preleukaemic states. Br. J. Haematol. 1984; 58: 71–81
   PubMed Web of Science ®Google Scholar
• Galvani D. W., Nethersell A. B. W., Cawley J. C. a-Interferon in myelodysplasia; clinical observations and effects on NK cells. Leukemia Res. 1988; 12: 257–262
   PubMed Web of Science ®Google Scholar
• Alvarez de Mon M., Casas J., Laguna R., Toribio M. L., Landazuri M. O., Durantez A. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL. Blood 1986; 67: 228–232
   PubMed Web of Science ®Google Scholar
• Sorskaar D., Forre 0., Stavem P. Natural killer cells in chronic leukemia. Function and markers. Int. Arch. Allergy. Appl. Immunol 1988; 87: 159–164
   PubMedGoogle Scholar
• Brouet J., Flandrin G., Sasportes M., Homme J.-L., Seligmann M. Chronic lymphocytic leukaemia of T-cell origin. Lancet 1975; 2: 890–893
   PubMed Web of Science ®Google Scholar
• Newland A. C., Catovsky D., Linch D., Cawley J. C., Beverley P., San Miguel J. F., Gordon-Smith E. C., Blecher T. E., Shahriari S., Varadi S. Chronic T cell lymphocytosis: a review of 21 cases. Br. J. Haematol. 1984; 58: 433–446
   PubMed Web of Science ®Google Scholar
• Editorial. Large granulr lymphocytic leukaemia. Lancet, 338: 284–285
   PubMedGoogle Scholar
• Semenzato G., Pandolfi F., Chisesi T., De Rossi G., Pizzolo G., Zambello K., Trentin L., Agostini C., Dini E., Vespignani M., Cafaro A., Pasqualetti D., Giubellino M. C., Migone N., Foa R. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60: 2971–2978
   PubMed Web of Science ®Google Scholar
• Loughran R. P., Starkebaum G. Large granular lymphocyte leukemia: Report of 38 cases and review of the literature. Medicine. 1987; 66: 397–405
   PubMed Web of Science ®Google Scholar
• Foa R., Matutes E., Forini L., Catovsky D., Brito-Babapulle V. T-cell chronic lymphocytic leukemia: A proliferation of large granular lymphocytes. Immunological, clinical, ultrastructural and molecular studies. T-cell chronic lymphocytic leukemia: A proliferation of large granular lymphocytes. Immunological, clinical, ultrastructural and molecular studies, A. Polliack, D. Catovsky. Harwood Academic Publishers, London 1988; 367–381
   Google Scholar
• Bassan R., Rambaldi A., Abbate M., Biondi A., Allavena P., Barbui T., Bertani T. Association of NK-cell lymphoproliferative disease and nephrotic syndrome. Am. J. Clin. Pathol 1990; 94: 334–338
   PubMed Web of Science ®Google Scholar
• Ault K. A., Lanier L. L. Terminology in Ty lymphoproliferative disease. Blood 1985; 66: 248–249
   PubMedGoogle Scholar
• Drexler H. G., Scott C. S. Morphological and immunological aspects of leukaemia diagnosis. Morphological and immunological aspects of leukaemia diagnosis, C. S. Scott. Ellis Horwood, Chichester 1989; 13–67
   Google Scholar
• Chan W. C., Link S., Mawle A., Check I., Byrnes R. K., Winton E. F. Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes. Blood 1986; 68: 1142–1153
   PubMed Web of Science ®Google Scholar
• Agnarsson B. A., Loughran T. P., Starkebaum G., Kadin M. E. The pathology of large granular lymphocyte leukemia. Hum. Pathol. 1989; 20: 643–651
   PubMed Web of Science ®Google Scholar
• Reynolds C. W., Foon K. A. T.-lymphoproliferative disease and related disorders in humans and experimental animals: A review of the clinical, cellular, and functional characteristics. Blood 1984; 64: 1146–1158
   PubMed Web of Science ®Google Scholar
• Mc Kenna R. W., Arthur D. C., Gajl-Peczalska K. J., Flynn P., Brunning R. D. Granulated T cell lymphocytosis with neutopenia: Malignant or benign chronic lymphoproliferative disorder?. Blood 1985; 66: 259–266
   PubMed Web of Science ®Google Scholar
• Pandolfi F., Loughran T. P., Starkebaum G., Chisesi T., Chan W. C. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. Cancer 1990; 65: 341–348
   PubMed Web of Science ®Google Scholar
• Pastor E., Sayas M. J. Severe neutopenia associated with large granular lymphocytosis: Successful control with cyclosporin A. Blut. 1989; 59: 501–502
   PubMedGoogle Scholar
• Kaneko T., Ogawa Y., Hirata Y., Hoshino S., Takahashi M., Oshimi K., Mizogichi H. Agranulocytosis associated with granular lymphocyte leukaemia: Improvement of peripheral blood granulocyte count with human recombinant granulocyte colony-stimulating factor (G-CFS). Br. J. Haematol. 1990; 74: 121–122
   PubMed Web of Science ®Google Scholar
• Lauria F., Foa R., Migone N., Giubellino M. C., Raspadori D., Buzzi M., Casorati G., Gobbi M., Tazzari P. L., Tura S. Heterogeneity of large granular lymphocyte proliferations: morphological, immunological and molecular analysis in seven patients. Br. J. Haematol 1987; 66: 187–191
   PubMed Web of Science ®Google Scholar
• Mc Kenna R. W., Parkin J., Kersey J. H., Gajl-Peczalska K. J., Peterson L., Brunning R. D. Chronic lymphoproliferative disorder with unusual clinical, morphological, ultrastructural and membrane surface markers. Am. J. Med 1977; 62: 588–596
   PubMed Web of Science ®Google Scholar
• Schlimok G., Thiel E., Rieber E. P., Huhn D., Feucht H., Lohmeyer J., Riethmuller G. Chronic leukemia with a hybrid surface phenotype (T lymphocytic/myelomono-cytic): Leukemic cells displayed natural activity and antibody-dependent cellular cytotoxicity. Blood 1982; 59: 1157–1162
   PubMed Web of Science ®Google Scholar
• Itoh K., Tsuchikawa K., Awataguchi T., Shiiba K., Kumagai K. A case of chronic lymphocytic leukemia with properties of natural killer cells. Blood 1983; 61: 940–948
   PubMed Web of Science ®Google Scholar
• Knowles D. M. Immunophenotypic and antigen receptor gene analysis in T cell neoplasia. Am. J. Pathol 1989; 134: 761–785
   PubMed Web of Science ®Google Scholar
• Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM and IgG. J. Clin. Invest. 1977; 146: 184–190
   Google Scholar
• Rumke H. C., Miedema F., Ten Berge I. J. M., Terpstra F., der Reijden H. J., Van de Griend R. J., De Bruin H. G., Von dem Borne A. E. G., Smit J. W., Zeijlemaker W. P., Melief C. J. M. Functional properties of T cells in patients with chronic Ty lymphocytosis and chronic T cell neoplasia. J. Immunol. 1982; 129: 419–425
   PubMed Web of Science ®Google Scholar
• Palutke M., Eisenberg L., Kaplan J., Hussain M., Kithier K., Tabaczka P., Mirchandani I., Tenenbaum D. Natural killer and suppressor T-cell chronic lymphocytic leukemia. Blood 1983; 62: 627–63
   PubMed Web of Science ®Google Scholar
• Tagawa, Konishi S., Karatune H., Katagiri S., Taniguchi N., Tamaki T., Inoue R., Kanayama Y., Tsubakio T., Machii T., Yoezawa T., Kitani T. A case of T-cell chronic lymphocytic leukemia (T-CLL) expressing a peculiar phenotype (E+, OKM1+, Leul+, OKT3−, and IgGEA−). Cancer 1983; 52: 1378–1384
   PubMed Web of Science ®Google Scholar
• Pandolfi F., Pezzuto A., de Rossi G., Pasqualetti D., Semenzato S., Quinti I., Ranucci A., Raimondi R., Basso G., Strong D. M., Fontana L., Auiti F. Characterization of two patients with lymphomas of large granular lymphocytes. Cancer 1984; 53: 445–452
   PubMed Web of Science ®Google Scholar
• Bakri K., Ezdinli E. Z., Wasser, Han L. P., Sinclair T., Singh S., Ozer H., Minowda J. T-suppressor cell chronic lymphocytic leukemia. Cancer 1984; 54: 284–289
   PubMed Web of Science ®Google Scholar
• Phyliky R. L., Li C.-Y., Yam L. T. T-cell chronic lymphocytic leukemia with morphologic and immunologic of cytotoxic/suppressor phenotype. Mayo Clin. Proc 1983; 58: 709–720
   PubMed Web of Science ®Google Scholar
• Quinti I., Pacilli L., Zoli V., De Sactis G., Mannella E., Bonomo G., De Laurenzi A., Pandolfi F. Unusual phenotype (Leu7 +, OKT4 +, OKM1 +) expressed by cells from a patient with an abnormal expansion of granular lymphocytes. Acta Haematol. 1984; 71: 310–315
   PubMed Web of Science ®Google Scholar
• Berrebi A., Talmor M., Vorst E. J., Shtalrid M., Polliack A., Nir E. Chronic T cell lymphocytosis with large granular lymphocytes of helper (OKT4) phenotype. Scand. J. Haematol 1985; 34: 160–169
   PubMedGoogle Scholar
• Koizumi S., Seki H., Tachinami T., Taniguchi, Matsuda M., Taga K., Nakarai T., Kato E., Taniguchi N., Nakamura H. Malignant clonal expansion of large granular lymphocytes with a leu-11+, leu-7− surface phenotype: In vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 1986; 68: 1065–1073
   PubMed Web of Science ®Google Scholar
• Forini L., Matutes E., Foldi J., Morlla R., Rabbitts T., Luzzatto L., Catovsky D. T-cell leukemias with rearrangement of the γ but not β T-cell receptor genes. Blood 1988; 71: 356–362
   PubMed Web of Science ®Google Scholar
• Ohno T., Kanoh T., Arita Y., Fujii H., Kuribayashi K., Masuda T., Horiguchi Y., Taniwaki M., Nosaka T., Hatanaka M., Uchino H. Fulminant clonal expansion of large granular lymphocytes: Characterization of their morphology, phenotype, genotype, and function. Cancer 1988; 62: 1918–1927
   PubMed Web of Science ®Google Scholar
• Lin C. K., Liu H. W., Tse P. W. T., Lai C. L., Chan G. T. C. A patient with large granular lymphocytosis of unusual phenotype and polymorphic T-cell receptor beta-chain gene rearrangement. Am. J. Clin. Pathol. 1990; 94: 211–216
   PubMed Web of Science ®Google Scholar
• Sansoni P., Girasole G., Manara G. C., Snelli G., Passeri G., Allavena P., Rossi V., De Panfilis G., Passeri M. Lymphocytes of patient with lymphoproliferative disease of large granular lymphocytes express high natural killer ADCC and LAK activity. Clin. Immunol. Immunopathol 1990; 56: 9–21
   PubMedGoogle Scholar
• Imamura N., Kusunoki Y., Kawa-Ha K., Yumura K., Hara J., Oda K., Abe K., Dohy H., Inada T., Kajihara H., Kuramoto A. Aggressive natural killer cell leukemia/lymphoma: Report of four cases and review of the literature. Br. J. Haematol. 1990; 75: 49–59
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Wills E. J., Young G. A. R. Exercise-induced CD8 lymphocytosis: A phenomenon associated with large granular lymphocyte leukaemia. Br. J. Haematol 1990; 75: 175–180
   PubMed Web of Science ®Google Scholar
• Le Deist F., de Saint Basile G., Coulombel L., Breton-Gorius J., Maier-Redelsperger M., Beljorde K., Bremard C., Griscelli C. A familial occurrence of natural killer cell-T-lymphocyte proliferation disease in two children. Cancer 1991; 67: 2610–261
   PubMed Web of Science ®Google Scholar
• Raziuddin S., Sheikha A., Teklu B. Humoral immunodeficiency in T-cell chronic lymphocytic leukemia. Cancer 1990; 64: 2518–2522
   Google Scholar
• Ainsberg A. C., Krontiris T. G., Mak T. W., Wilkes B. M. Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. New Engl. J. Med. 1985; 313: 529–533
   PubMed Web of Science ®Google Scholar
• Bertness V., Kirsch I., Hollis G., Johnson B., Bunn P. A. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. New Engl. J. Med. 1985; 313: 534–538
   PubMed Web of Science ®Google Scholar
• Foa R., Pellici P.-G., Migone N., Lauria F., Pizzola G., Flug F., Knowles D. M., Dalla-Favera R. Analysis of T-cell receptor beta chain (Tβ) gene rearrangements demonstrates the monoclonal nature of T-cell chronic lymphoproliferative disorders. Blood 1986; 64: 247–250
   Google Scholar
• Waldmann T. A., Davis M. M., Bongiovanni K. F., Korsmeyer S. J. Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. New Engl. J. Med. 1985; 313: 776–783
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Pelicci P.-R., Allavena P., Knowles D. M., Rossini S., Bassan R., Barbui T., Dalla-Fevera R., Mantovani A. T cell receptor β chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells. J. Exp. Med. 1985; 162: 2156–2162
   PubMed Web of Science ®Google Scholar
• Berliner N., Duby A. D., Linch D. C., Mure C., Quertermous T., Knott L. J., Azin T., Newland A. C., Lewis D. L., Galvin M. C., Seidman J. G. T cell receptor gene rearrangement define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood 1986; 67: 914–918
   PubMed Web of Science ®Google Scholar
• Brenner M. B., McLean J., Scheft H., Riberdy J., Ang S.-L., Seidman J. G., Devlin P., Krangel M. S. Two forms of the T-cell receptor γ protein found on peripheral blood cytotoxic lymphocytes. Nature 1987; 325: 689–694
   PubMed Web of Science ®Google Scholar
• Borst J., Griend R. J., Ang J. W., Melief C. J., Seidman J. G., Bolhuis R. L. H. A T-cell receptor γ/CD3 complex found on cloned functional lymphocytes. Nature 1987; 325: 683–688
   PubMed Web of Science ®Google Scholar
• Oshimi K., Hoshino S., Takahashi M., Akahoshi M., Saito H., Kobayashi Y., Hirai H., Takaku F., Yahagi N., Oshimi Y., Horie Y., Mizoguchi H. Ti (WT31)-negative, CD3-positive, large granular lymphocyte leukemia with nonspecific cytotoxicity. Blood 1988; 71: 923–93
   PubMed Web of Science ®Google Scholar
• Loughran T. P., Starkebaum G., Aprile J. A. Rearrangement and expression of T-cell receptor genes in large granular lymphocyte leukemia. Blood 1988; 71: 822–824
   PubMed Web of Science ®Google Scholar
• Pelicci P.-C, Allavena P., Subar M., Rambaldi A., Pirelli A., Bello M. D., Barbui T., Knowles D. M., Dalla-Fevera R., Mantovani A. T cell receptor (α, β, γ) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells. Blood 1987; 70: 1500–1508
   PubMed Web of Science ®Google Scholar
• Scott C. S., Richards S. J., Sivakumaran M. Large granular lymphocytes. Lancet 1991; 338: 898
   PubMed Web of Science ®Google Scholar
• Sivakumaran M., Richards S. J., Hunt K. M., Steed A. J., Bynoe A. G., Morgan M. M., Pyrah R., Roberts B. E., Scott C. S. Patterns of CD 16 and CD56 expression in persistent expansions of CD3 + Nka+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. Br. J. Haematol. 1991; 78: 368–377
   PubMed Web of Science ®Google Scholar
• Pandolfi F. T-CLL and allied diseases: New insights into classification and pathogenesis. Diagnost. Immunol. 1986; 4: 61–74
   PubMedGoogle Scholar
• Taniwaki M., Tagawa S., Nishigaki H., Horlike S., Misawa S., Shimazaki C., Maekawa T., Fuji H., Kitani T., Abe T. Chromosomal abnormalities define clonal proliferation in CD3− large granular lymphocyte leukemia. Am. J. Haematol. 1990; 33: 32–38
   PubMed Web of Science ®Google Scholar
• Bassan R., Rambaldi A., Allavena P., Abbate M., Marini B., Barbui T. Association of large granular lymphocyte/natural killer cell proliferative disease and second hematologic malignancy. Am. J. Haematol. 1988; 29: 85–93
   PubMed Web of Science ®Google Scholar
• Semple J. W., Bruce S., Freedman J. Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am. J. Hemaiol 1991; 37: 258–262
   PubMed Web of Science ®Google Scholar
• Warzynski M. J., White C., Golightly M. G., Steingart R., Otto R. N., Podgurski A. E., Johnson M. L., Glynn P., Smith D. E. Natural killer lymphocyte blast crisis of chronic myelogenous leukemia. Am. J. Hematoi 1989; 32: 279–286
   PubMed Web of Science ®Google Scholar
• Sun T., Cohen N. S., Marino J., Koduru P., Cuomo J., Henshall J. CD3+, CD4−, CD8− large granular T-cell lymphoproliferative disorder. Am. J. Hematol 1991; 37: 173–178
   PubMed Web of Science ®Google Scholar
• Scott C. S., Richards S. J., Milligan D., Steed A. J., Norfolk D. R. Clonal expansions of TCRγ⁺ lymphocytes associated with severe neutropenia: in preparation. 1992
   Google Scholar
• Pizzolo G., Trentin L., Vinante F., Agostini C., Zambello R., Ranucci A., Luca M., Chilosi M., Dazzi F., Foa R., Caligaris-Cappio F., Perona G., Semenzato G. Rearrangement for the T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia. Br. J. Haematol. 1987; 65: 17–22
   PubMed Web of Science ®Google Scholar
• Pirruccello S. J., Bicak M. S., Gordon B. G., Gajl-Peczalska K., Gnarra D. J., Coccia P. F. Acute lymphoblastic leukemia of NK-cell lineage: Responses to IL-2. Leuk. Res. 1989; 13: 735–743
   PubMed Web of Science ®Google Scholar
• Cerezo L., Shuster J. J., Pullen J., Brock B., Borowitz M. J., Falletta J. M., Crist W. M., Head D. R. Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. Am. J. Clin. Pathol. 1991; 95: 526–531
   PubMed Web of Science ®Google Scholar
• Imamura N., Kusunoki Y., Kajihara H., Okada K., Kuramoto A. Aggressive natural killer cell leukemia/lymphoma with N901-positive surface phenotype: Evidence for the existence of a third lineage in lymphoid cells. Acta Haematol. 1988; 80: 121–128
   PubMed Web of Science ®Google Scholar